MJRIC
TMO icon

Mogy Joel R Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Mogy Joel R Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,006
Closed -$15.4M – 128
2025
Q1 		$15.4M Buy
31,006
+3,374
+12% +$1.83M 0.99% 26
2024
Q4 		$14.4M Buy
27,632
+1,071
+4% +$589K 0.85% 29
2024
Q3 		$16.4M Buy
26,561
+656
+3% +$388K 1.01% 27
2024
Q2 		$14.3M Buy
25,905
+1,506
+6% +$863K 0.91% 28
2024
Q1 		$14.2M Buy
24,399
+1,378
+6% +$773K 0.96% 28
2023
Q4 		$12.2M Sell
23,021
-163
-0.7% -$78.9K 0.92% 29
2023
Q3 		$11.7M Buy
23,184
+642
+3% +$342K 0.99% 27
2023
Q2 		$11.8M Buy
22,542
+1,044
+5% +$563K 0.93% 29
2023
Q1 		$12.4M Buy
21,498
+528
+3% +$298K 1.1% 28
2022
Q4 		$11.5M Buy
20,970
+406
+2% +$215K 1.16% 28
2022
Q3 		$10.4M Buy
20,564
+387
+2% +$217K 1.09% 29
2022
Q2 		$11M Buy
20,177
+360
+2% +$198K 1.08% 31
2022
Q1 		$11.7M Buy
19,817
+510
+3% +$293K 0.93% 32
2021
Q4 		$12.9M Buy
19,307
+843
+5% +$526K 0.92% 32
2021
Q3 		$10.5M Buy
18,464
+843
+5% +$463K 0.86% 33
2021
Q2 		$8.89M Buy
17,621
+3,811
+28% +$1.8M 0.75% 33
2021
Q1 		$6.3M Buy
13,810
+5,478
+66% +$2.61M 0.61% 36
2020
Q4 		$3.88M Buy
8,332
+837
+11% +$392K 0.38% 42
2020
Q3 		$3.31M Buy
7,495
+1,371
+22% +$566K 0.36% 43
2020
Q2 		$2.22M Buy
+6,124
New +$2.05M 0.27% 48

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Mogy Joel R Investment Counsel's TMO Position: Q2 2025 in Review

Mogy Joel R Investment Counsel sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 31,006 shares — an estimated $15.4M sold.

Mogy Joel R Investment Counsel first reported a position in TMO in Q2 2020 and held it in 20 quarters. The position peaked at $16.4M in Q3 2024. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Mogy Joel R Investment Counsel reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Mogy Joel R Investment Counsel sold 31,006 Thermo Fisher Scientific shares in Q2 2025, an estimated $15.4M.
  • Mogy Joel R Investment Counsel first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 20 quarters.
  • Mogy Joel R Investment Counsel's Thermo Fisher Scientific position peaked at $16.4M in Q3 2024.
  • 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Mogy Joel R Investment Counsel's 13F filing for Q2 2025, filed 10 Jul 2025.